The Drug Controller General of India (DCGI) has granted approval to Dr Reddy’s, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human trials of the Sputnik V, which is Russian origin Covid-19 vaccine.   On September 16, the Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Limited had … Continue reading Russian Covid-19 vaccine ” Sputnik V” approved for final clinical trials in India : DCGI